The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
GCLLSG 2016 | Can concepts from CLL be applied to other liquid and solid tumors?
Paolo Ghia, MD, PhD of Università Vita-Salute San Raffaele, Milan, Italy believes chronic lymphocytic leukemia (CLL) is at the forefront of research both in hematology and solid tumors. Concepts such as the microenvironment, which has been known in CLL for two decades, is now becoming a hot topic also in solid cancer. The idea to modify and target the cells of the microenvironment (and not directly only the tumor cells), is becoming a concept that is utilized also in solid tumors. All the knowledge gathered in CLL research can be easily translated also to B-cell lymphoma cells and tested there. Recorded at the 2016 International Workshop of the German CLL Study Group (GCLLSG) in Cologne, Germany.
